Zhang Lihai, Wu Jiaxin, Ruan Ke-He
Vascular Biology Research Center and Division of Hematology, Department of Internal Medicine, The University of Texas Health Science Center, Houston, Texas 77030, USA.
Biochemistry. 2006 Feb 14;45(6):1734-44. doi: 10.1021/bi0515669.
The amino acids (residues 39-51) responsible for the interaction between the first intracellular loop (iLP1) of the human prostacyclin receptor (IP) and G alpha s protein have been identified [Zhang, L., Huang, G., Wu, J., and Ruan, K. H. (2005) Biochemistry 44, 11389-11401]. To further characterize the structural/functional relationship of the iLP1 in coupling with the G alpha s protein, the solution structures of a constrained peptide (IP iLP1) that mimicked the iLP1 of the IP receptor in the absence and presence of a synthetic peptide, corresponding to the C-terminal 11 residues (Q384-L394 in the protein sequence) of the G alpha s protein (G alpha s-Ct), were determined by 2D 1H NMR spectroscopy. The NMR solution structural model of the iLP1 domain showed two turn structures in residues Arg41-Ala44 and Arg45-Phe49 with the conserved Arg45 at the center. The conformational change of the side chain of the Arg45 was observed upon the addition of the G alpha s-Ct peptide. On the other hand, the solution structural models of the G alpha s-Ct peptide in the absence and presence of the IP iLP1 peptide were also determined. The N-terminal domain (Q384-Q390 in the G alpha s protein) of the peptide adopted an alpha-helical conformation. However, the helical structure of the C-terminal domain (Q390-E392 in the G alpha s protein) of the peptide was destabilized upon addition of the IP iLP1 peptide. These structural studies have implied that there are direct or indirect contacts between the IP iLP1 domain and the C-terminal residues of the G alpha s protein in the receptor/G protein coupling. The possible charge and hydrophobic interactions between the two peptides were also discussed. These data prompted intriguing speculations on the IP/G alpha s coupling which mediates vasodilatation and inhibition of platelet aggregation.
负责人类前列环素受体(IP)的第一个细胞内环(iLP1)与Gαs蛋白相互作用的氨基酸(残基39 - 51)已被确定[Zhang, L., Huang, G., Wu, J., and Ruan, K. H. (2005) Biochemistry 44, 11389 - 11401]。为了进一步表征iLP1与Gαs蛋白偶联的结构/功能关系,通过二维¹H NMR光谱法测定了一种受限肽(IP iLP1)在不存在和存在对应于Gαs蛋白C末端11个残基(蛋白质序列中的Q384 - L394)的合成肽(Gαs - Ct)时模拟IP受体iLP1的溶液结构。iLP1结构域的NMR溶液结构模型显示在残基Arg41 - Ala44和Arg45 - Phe49中有两个转角结构,保守的Arg45位于中心。添加Gαs - Ct肽后观察到Arg45侧链的构象变化。另一方面,还测定了不存在和存在IP iLP1肽时Gαs - Ct肽的溶液结构模型。该肽的N末端结构域(Gαs蛋白中的Q384 - Q390)呈α螺旋构象。然而,添加IP iLP1肽后,该肽的C末端结构域(Gαs蛋白中的Q390 - E392)的螺旋结构不稳定。这些结构研究表明,在受体/G蛋白偶联中,IP iLP1结构域与Gαs蛋白的C末端残基之间存在直接或间接接触。还讨论了两种肽之间可能的电荷和疏水相互作用。这些数据引发了关于介导血管舒张和抑制血小板聚集的IP/Gαs偶联的有趣推测。